Date: Thursday, April 15, 2021
Virtual Conference
Time (JST) | Session | Name |
---|---|---|
13:00-13:03 | Opening remarks | Ken-ichiro Hata, FIRM |
13:03-13:10 | Introduction | Masayuki Nomura, FIRM |
13:10-14:10 | Update on Regenerative Medicine from each Participating Industrial Association | |
10-min presentations from each country/region | Yoshitsugu Shitaka, FIRM (Japan) | |
Tsui Yat Ping Alex, CMBA (China) | ||
Bryan Choi, CARM & SCRM (Korea) | ||
Wong, Kum Cheun, SAPI (Singapore) | ||
Pawan Kumar Gupta, ABLE (India) | ||
Shinn-Zong (John) Lin, BPIPO (Taiwan) | ||
14:10-15:40 | Working group 1 (WG1) activity | |
Presentation | Presenter : Tomohiro Yoneda | |
Panel Discussion - pharmacology, biodistribution, toxicity, tumorigenicity | Facilitator : Tomohiro Yoneda | |
15:40-15:50 | Break | |
15:50-17:05 | Working group 2 (WG2) activity | |
Latest information sharing | Presenter : Yoji Sato, NIHS | |
Presentation | Presenter : Toshimitsu Tanaka Presenter : Shing-Mou Lee |
|
Panel Discussion - starting cells, comparability | Facilitator:Ryan Chang Facilitator : Shinobu Kuwae |
|
17:05-17:45 | Other topics (Facilitator : Yoshie Tsurumaki, FIRM ) | |
Actual experiences with early approval | Presenter : Keiji Yoshimura | |
Reimbursement system | Presenter : Keiji Yoshimura | |
17:45-18:10 | Introduction and Exchange opinions for next activities | |
WG1 introduction | Presenter : Tomohiro Yoneda | |
WG2 introduction | Presenter : Toshimitsu Tanaka | |
Others (exchange opinions) | Presenter : Yoshie Tsurumaki | |
18:10-18:15 | Closing Remarks | Kunihiko Suzuki, FIRM |
Abbreviations: CMBA, China Medical Biotech Association in China; CARM, Council for Advanced Regenerative Medicine in Korea; SCRM, Strategic Center for Regenerative Medicine in Korea; SAPI, Singapore Association of Pharmaceuticals Industries in Singapore; ABLE, Association of Biotechnology Led Enterprises in India; BPIPO, Biotechnology and Pharmaceutical Industries Promotion Office in Taiwan. NIHS, National Institute of Health Sciences in Japan.